IQVIA Holdings Net Common Equity Issued/Repurchased 2011-2025 | IQV
IQVIA Holdings annual/quarterly net common equity issued/repurchased history and growth rate from 2011 to 2025. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
- IQVIA Holdings net common equity issued/repurchased for the quarter ending March 31, 2025 was $-0.410B, a 583.33% increase year-over-year.
- IQVIA Holdings net common equity issued/repurchased for the twelve months ending March 31, 2025 was $-2.145B, a 17.85% decline year-over-year.
- IQVIA Holdings annual net common equity issued/repurchased for 2024 was $-1.414B, a 34.28% increase from 2023.
- IQVIA Holdings annual net common equity issued/repurchased for 2023 was $-1.053B, a 15.01% decline from 2022.
- IQVIA Holdings annual net common equity issued/repurchased for 2022 was $-1.239B, a 166.45% increase from 2021.
| IQVIA Holdings Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2024 | $-1,414 |
| 2023 | $-1,053 |
| 2022 | $-1,239 |
| 2021 | $-465 |
| 2020 | $-491 |
| 2019 | $-938 |
| 2018 | $-1,390 |
| 2017 | $-2,529 |
| 2016 | $-1,000 |
| 2015 | $-451 |
| 2014 | $-388 |
| 2013 | $480 |
| 2012 | $-10 |
| 2011 | $-13 |
| 2010 | $-9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $24.832B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $201.298B | 88.17 |
| Thermo Fisher Scientific (TMO) | United States | $156.252B | 18.90 |
| Edwards Lifesciences (EW) | United States | $45.778B | 30.01 |
| Alcon (ALC) | Switzerland | $44.076B | 29.79 |
| IDEXX Laboratories (IDXX) | United States | $41.955B | 48.21 |
| DexCom (DXCM) | United States | $34.098B | 52.70 |
| STERIS (STE) | Ireland | $24.813B | 27.36 |
| Mettler-Toledo (MTD) | United States | $24.089B | 28.65 |
| Waters (WAT) | United States | $21.336B | 30.10 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.297B | 0.00 |
| Hologic (HOLX) | United States | $12.575B | 13.66 |
| Penumbra (PEN) | United States | $10.904B | 85.58 |
| Sysmex ADR (SSMXY) | Japan | $10.525B | 29.86 |
| Masimo (MASI) | United States | $8.411B | 31.03 |
| Globus Medical (GMED) | United States | $8.397B | 19.69 |
| Teleflex (TFX) | United States | $5.662B | 9.35 |
| Glaukos (GKOS) | United States | $5.477B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.238B | 22.20 |
| TransMedics (TMDX) | United States | $4.130B | 89.78 |
| PROCEPT BioRobotics (PRCT) | United States | $3.280B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.398B | 14.28 |
| Veracyte (VCYT) | United States | $2.271B | 31.87 |
| Nihon Kohden (NHNKY) | Japan | $2.119B | 24.30 |
| Elekta AB (EKTAY) | Sweden | $2.079B | 18.69 |
| Alphatec Holdings (ATEC) | United States | $1.905B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.514B | 0.00 |
| Artivion (AORT) | United States | $1.269B | 118.84 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.053B | 5.60 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| IRadimed (IRMD) | United States | $0.689B | 34.97 |
| RxSight (RXST) | United States | $0.663B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.655B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.644B | 14.08 |
| Delcath Systems (DCTH) | United States | $0.630B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.601B | 9.35 |
| NeuroPace (NPCE) | United States | $0.558B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.557B | 0.00 |
| AxoGen (AXGN) | United States | $0.536B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 12.84 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.471B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.367B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.306B | 0.00 |
| Neuronetics (STIM) | United States | $0.282B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.218B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| CVRx (CVRX) | United States | $0.179B | 0.00 |
| 908 Devices (MASS) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Inogen (INGN) | United States | $0.165B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.145B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.127B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.30 |
| EDAP TMS S.A (EDAP) | France | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.069B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.50 |
| Hyperfine (HYPR) | United States | $0.049B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.66 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |